Age, creatinine, and ejection fraction (ACEF) score as predictive values for late non-valvular atrial fibrillation recurrence after radiofrequency ablation

References

• Waldmann V, Jouven X, Narayanan K, Piot O, Chugh SS, Albert CM, Marijon E. Association between atrial fibrillation and sudden cardiac death: pathophysiological and epidemiological insights. Circ Res. 2020;127(2):301–9. doi:10.1161/CIRCRESAHA.120.316756. Cited in: PMID: 32833581.
   PubMed Web of Science ®Google Scholar
• Calkins H, Hindricks G, Cappato R, Kim YH, Saad EB, Aguinaga L, Akar JG, Badhwar V, Brugada J, Camm J, et al. 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: executive summary. Heart Rhythm. 2017;14(10):e445–94. doi:10.1016/j.hrthm.2017.07.009. Cited in: PMID: 31631881.
   PubMed Web of Science ®Google Scholar
• Achkasov E, Bondarev S, Smirnov V, Waśkiewicz Z, Rosemann T, Nikolaidis PT, Knechtle B. Atrial fibrillation in athletes-features of development, current approaches to the treatment, and prevention of complications. Int J Environ Res Public Health. 2019;16(24):4890. doi:10.3390/ijerph16244890. Cited in: PMID: 31817190; PMCID: PMC6950061.
   PubMed Web of Science ®Google Scholar
• Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B, Castella M, Diener HC, Heidbuchel H, Hendriks J, et al. ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Europace. 2016;18(11):1609–78. doi:10.1093/europace/euw295. 2016 Cited in: PMID: 27567465.
   PubMed Web of Science ®Google Scholar
• Roth GA, Mensah GA, Johnson CO, Addolorato G, Ammirati E, Baddour LM, Barengo NC, Beaton AZ, Benjamin EJ, Benziger CP, et al. Global burden of cardiovascular diseases writing group. global burden of cardiovascular diseases and risk factors, 1990-2019: update from the GBD 2019 Study. J Am Coll Cardiol. 2020;76(25):2982–3021. doi:10.1016/j.jacc.2020.11.010. Erratum in: J Am Coll Cardiol. 2021;77(15):1958-1959. Cited in: PMID: 33309175; PMCID: PMC7755038.
   PubMed Web of Science ®Google Scholar
• Lippi G, Sanchis-Gomar F, Cervellin G. Global epidemiology of atrial fibrillation: an increasing epidemic and public health challenge. Int J Stroke. 2021;16(2):217–21. doi:10.1177/1747493019897870. Erratum in: Int J Stroke. 2020:1747493020905964. Cited in: PMID: 31955707.
   PubMed Web of Science ®Google Scholar
• Kornej J, Börschel CS, Benjamin EJ, Schnabel RB. Epidemiology of atrial fibrillation in the 21st century: novel methods and new insights. Circ Res. 2020 Jun 19;127(1):4–20. doi:10.1161/CIRCRESAHA.120.316340. Cited in: PMID: 32716709; PMCID: PMC7577553.
   PubMed Web of Science ®Google Scholar
• Asad ZUA, Yousif A, Khan MS, Al-Khatib SM, Stavrakis S. Catheter ablation versus medical therapy for atrial fibrillation: a systematic review and meta-analysis of randomized controlled trials. Circ Arrhythm Electrophysiol. 2019;12(9):e007414. doi:10.1161/CIRCEP.119.007414. Cited in: PMID: 31431051.
   PubMed Web of Science ®Google Scholar
• Turagam MK, Musikantow D, Whang W, Koruth JS, Miller MA, Langan MN, Sofi A, Choudry S, Dukkipati SR, Reddy VY. Assessment of catheter ablation or antiarrhythmic drugs for first-line therapy of atrial fibrillation: a meta-analysis of randomized clinical trials. JAMA Cardiol. 2021;6(6):697–705. doi:10.1001/jamacardio.2021.0852. Cited in: PMID: 33909022; PMCID: PMC8082432.
   PubMed Web of Science ®Google Scholar
• Zink MD, Chua W, Zeemering S, di Biase L, Antoni BL, David C, Hindricks G, Haeusler KG, Al-Khalidi HR, Piccini JP, et al. Predictors of recurrence of atrial fibrillation within the first 3 months after ablation. Europace. 2020;22(9):1337–44. doi:10.1093/europace/euaa132. Cited in: PMID: 32725107; PMCID: PMC7478316.
   PubMed Web of Science ®Google Scholar
• Kızılırmak F, Gokdeniz T, Gunes HM, Demir GG, Cakal B, Guler GB, Guler E, Olgun FE, Kilicaslan F. Myocardial injury biomarkers after radiofrequency catheter and cryoballoon ablation for atrial fibrillation and their impact on recurrence. Kardiol Pol. 2017;75(2):126–34. doi:10.5603/KP.a2016.0089. Cited in: PMID: 27221959.
   PubMed Web of Science ®Google Scholar
• Dodson JA, Neilan TG, Shah RV, Farhad H, Blankstein R, Steigner M, Michaud GF, John R, Abbasi SA, Jerosch-Herold M, et al. Left atrial passive emptying function determined by cardiac magnetic resonance predicts atrial fibrillation recurrence after pulmonary vein isolation. Circ Cardiovasc Imaging. 2014;7(4):586–92. doi:10.1161/CIRCIMAGING.113.001472. Cited in: PMID: 24902586; PMCID: PMC4219259.
   PubMed Web of Science ®Google Scholar
• Zakeri R, Van Wagoner DR, Calkins H, Wong T, Ross HM, Heist EK, Meyer TE, Kowey PR, Mentz RJ, Cleland JG, et al. The burden of proof: the current state of atrial fibrillation prevention and treatment trials. Heart Rhythm. 2017;14(5):763–82. doi:10.1016/j.hrthm.2017.01.032. Cited in: PMID: 28161513; PMCID: PMC5403606.
   PubMed Web of Science ®Google Scholar
• Weiner DE, Tabatabai S, Tighiouart H, Elsayed E, Bansal N, Griffith J, Salem DN, Levey AS, Sarnak MJ. Cardiovascular outcomes and all-cause mortality: exploring the interaction between CKD and cardiovascular disease. Am J Kidney Dis. 2006;48(3):392–401. doi:10.1053/j.ajkd.2006.05.021. Cited in: PMID: 16931212.
   PubMed Web of Science ®Google Scholar
• Schrier RW. Role of diminished renal function in cardiovascular mortality: marker or pathogenetic factor? J Am Coll Cardiol. 2006;47(1):1–8. doi:10.1016/j.jacc.2005.07.067. Cited in: PMID: 16386657.
   PubMed Web of Science ®Google Scholar
• Gansevoort RT, Correa-Rotter R, Hemmelgarn BR, Jafar TH, Heerspink HJ, Mann JF, Matsushita K, Wen CP. Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention. Lancet. 2013;382(9889):339–52. doi:10.1016/S0140-6736(13)60595-4. Cited in: PMID: 23727170.
   PubMed Web of Science ®Google Scholar
• Van der Burgh AC, Geurts S, Ikram MA, Hoorn EJ, Kavousi M, Chaker L. Bidirectional association between kidney function and atrial fibrillation: a population-based cohort study. J Am Heart Assoc. 2022;11(10):e025303. doi:10.1161/JAHA.122.025303. Cited in: PMID: 35579615; PMCID: PMC9238570.
   PubMed Web of Science ®Google Scholar
• Shlipak MG, Sarnak MJ, Katz R, Fried LF, Seliger SL, Newman AB, Siscovick DS, Stehman-Breen C. Cystatin C and the risk of death and cardiovascular events among elderly persons. N Engl J Med. 2005;352(20):2049–60. doi:10.1056/NEJMoa043161. Cited in: PMID: 15901858.
   PubMed Web of Science ®Google Scholar
• Sullivan PG, Wallach JD, Ioannidis JP. Meta-analysis comparing established risk prediction models (EuroSCORE II, STS score, and ACEF score) for perioperative mortality during cardiac surgery. Am J Cardiol. 2016;118(10):1574–82. doi:10.1016/j.amjcard.2016.08.024. Cited in: PMID: 27687052.
   PubMed Web of Science ®Google Scholar
• Ranucci M, Castelvecchio S, Menicanti L, Frigiola A, Pelissero G. Risk of assessing mortality risk in elective cardiac operations: age, creatinine, ejection fraction, and the law of parsimony. Circulation. 2009;119(24):3053–61. doi:10.1161/CIRCULATIONAHA.108.842393. Cited in: PMID: 19506110.
   PubMed Web of Science ®Google Scholar
• Wykrzykowska JJ, Garg S, Onuma Y, de Vries T, Goedhart D, Morel MA, van Es GA, Buszman P, Linke A, Ischinger T, et al. Value of age, creatinine, and ejection fraction (ACEF score) in assessing risk in patients undergoing percutaneous coronary interventions in the ‘All-Comers’ LEADERS trial. Circ Cardiovasc Interv. 2011;4(1):47–56. doi:10.1161/CIRCINTERVENTIONS.110.958389. Cited in: PMID: 21205944.
   PubMed Web of Science ®Google Scholar
• Ding B, Liu P, Zhang F, Hui J, He L. Predicting Values of Neutrophil-to-Lymphocyte Ratio (NLR), High-sensitivity C-Reactive Protein (hs-CRP), and Left Atrial Diameter (LAD) in patients with nonvalvular atrial fibrillation recurrence after radiofrequency ablation. Med Sci Monit. 2022;28:e934569. doi:10.12659/MSM.934569. Cited in: PMID: 35082255; PMCID: PMC8805343.
   PubMed Web of Science ®Google Scholar
• Vaziri SM, Larson MG, Benjamin EJ, Levy D. Echocardiographic predictors of nonrheumatic atrial fibrillation. The Framingham heart study. Circulation. 1994;89(2):724–30. doi:10.1161/01.cir.89.2.724. Cited in: PMID: 8313561.
   PubMed Web of Science ®Google Scholar
• Packer DL, Piccini JP, Monahan KH, Al-Khalidi HR, Silverstein AP, Noseworthy PA, Poole JE, Bahnson TD, Lee KL, Mark DB. CABANA Investigators. Ablation versus drug therapy for atrial fibrillation in heart failure: results from the CABANA trial. Circulation. 2021;143(14):1377–90. doi:10.1161/CIRCULATIONAHA.120.050991. Cited in: PMID: 33554614; PMCID: PMC8030730.
   PubMed Web of Science ®Google Scholar
• Sagnard A, Hammache N, Sellal JM, Guenancia C. New perspective in atrial fibrillation. J Clin Med. 2020;9(11):3713. doi:10.3390/jcm9113713. Cited in: PMID: 33228053; PMCID: PMC7699334.
   PubMed Web of Science ®Google Scholar
• Hu YF, Chen YJ, Lin YJ, Chen SA. Inflammation and the pathogenesis of atrial fibrillation. Nat Rev Cardiol. 2015;12(4):230–43. doi:10.1038/nrcardio.2015.2. Cited in: PMID: 25622848.
   PubMed Web of Science ®Google Scholar
• Li J, Solus J, Chen Q, Rho YH, Milne G, Stein CM, Darbar D. Role of inflammation and oxidative stress in atrial fibrillation. Heart Rhythm. 2010;7(4):438–44. doi:10.1016/j.hrthm.2009.12.009. Cited in: PMID: 20153266; PMCID: PMC2843774.
   PubMed Web of Science ®Google Scholar
• Frustaci A, Chimenti C, Bellocci F, Morgante E, Russo MA, Maseri A. Histological substrate of atrial biopsies in patients with lone atrial fibrillation. Circulation. 1997;96(4):1180–84. doi:10.1161/01.cir.96.4.1180. Cited in: PMID: 9286947.
   PubMed Web of Science ®Google Scholar
• Soliman EZ, Prineas RJ, Go AS, Xie D, Lash JP, Rahman M, Ojo A, Teal VL, Jensvold NG, Robinson NL, et al. Chronic Renal Insufficiency Cohort (CRIC) study group. Chronic kidney disease and prevalent atrial fibrillation: the Chronic Renal Insufficiency Cohort (CRIC). Am Heart J. 2010;159(6):1102–07. 10.1016/j.ahj.2010.03.027. Erratum in: Am Heart J. 2011;162(4):794. Erratum in: Am Heart J. 2010;160(6):1190. Cited in: PMID: 20569726; PMCID: PMC2891979
   PubMed Web of Science ®Google Scholar
• Bansal N, Fan D, Hsu CY, Ordonez JD, Marcus GM, Go AS. Incident atrial fibrillation and risk of end-stage renal disease in adults with chronic kidney disease. Circulation. 2013;127(5):569–74. doi:10.1161/CIRCULATIONAHA.112.123992. Cited in: PMID: 23275377; PMCID: PMC3676734.
   PubMed Web of Science ®Google Scholar
• Hawkins NM, Jhund PS, Pozzi A, O’Meara E, Solomon SD, Granger CB, Yusuf S, Pfeffer MA, Swedberg K, Petrie MC, et al. Severity of renal impairment in patients with heart failure and atrial fibrillation: implications for non-vitamin K antagonist oral anticoagulant dose adjustment. Eur J Heart Fail. 2016;18(9):1162–71. doi:10.1002/ejhf.614. Cited in: PMID: 27594177.
   PubMed Web of Science ®Google Scholar
• Iso K, Nagashima K, Arai M, Watanabe R, Yokoyama K, Matsumoto N, Otsuka T, Suzuki S, Hirata A, Murakami M, et al. AF ablation frontier registry investigators. Clinical outcomes of ablation versus non-ablation therapy for atrial fibrillation in Japan: analysis of pooled data from the AF frontier ablation registry and SAKURA AF Registry. Heart Vessels. 2021;36(4):549–60. doi:10.1007/s00380-020-01721-x. Cited in: PMID: 33236221.
   PubMed Web of Science ®Google Scholar
• Kornej J, Hindricks G, Shoemaker MB, Husser D, Arya A, Sommer P, Rolf S, Saavedra P, Kanagasundram A, Patrick Whalen S, et al. The APPLE score: a novel and simple score for the prediction of rhythm outcomes after catheter ablation of atrial fibrillation. Clin Res Cardiol. 2015;104(10):871–76. doi:10.1007/s00392-015-0856-x. Cited in: PMID: 25876528; PMCID: PMC4726453.
   PubMed Web of Science ®Google Scholar
• Kosiuk J, Dinov B, Kornej J, Acou WJ, Schönbauer R, Fiedler L, Buchta P, Myrda K, Gąsior M, Poloński L, et al. Prospective, multicenter validation of a clinical risk score for left atrial arrhythmogenic substrate based on voltage analysis: dR-FLASH score. Heart Rhythm. 2015;12(11):2207–12. doi:10.1016/j.hrthm.2015.07.003. Cited in: PMID: 26144350.
   PubMed Web of Science ®Google Scholar
• Letsas KP, Efremidis M, Giannopoulos G, Deftereos S, Lioni L, Korantzopoulos P, Vlachos K, Xydonas S, Kossyvakis C, Sideris A. CHADS2 and CHA2DS2-VASc scores as predictors of left atrial ablation outcomes for paroxysmal atrial fibrillation. Europace. 2014;16(2):202–07. doi:10.1093/europace/eut210. Cited in: PMID: 23813452.
   PubMed Web of Science ®Google Scholar
• Authors/Task Force members, Windecker S, Kolh P, Alfonso F, Collet JP, Cremer J, Falk V, Filippatos G, Hamm C, Head SJ, et al. ESC/EACTS Guidelines on myocardial revascularization: the task force on myocardial revascularization of the European Society of Cardiology (ESC) and the European association for cardio-thoracic surgery (Eacts)developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J.2014;35(37):2541–619. 10.1093/eurheartj/ehu278. 2014 Cited in: PMID: 25173339.
   PubMed Web of Science ®Google Scholar
• Bahnson TD, Giczewska A, Mark DB, Russo AM, Monahan KH, Al-Khalidi HR, Silverstein AP, Poole JE, Lee KL, Packer DL, et al. Association between age and outcomes of catheter ablation versus medical therapy for atrial fibrillation: results from the CABANA trial. Circulation. 2022;145(11):796–804. doi:10.1161/CIRCULATIONAHA.121.055297. Cited in: PMID: 34933570; PMCID: PMC9003625.
   PubMed Web of Science ®Google Scholar
• Russo AM, Zeitler EP, Giczewska A, Silverstein AP, Al-Khalidi HR, Cha YM, Monahan KH, Bahnson TD, Mark DB, Packer DL, et al. Association between sex and treatment outcomes of atrial fibrillation ablation versus drug therapy: results from the CABANA trial. Circulation. 2021;143(7):661–72. doi:10.1161/CIRCULATIONAHA.120.051558. Cited in: PMID: 33499668; PMCID: PMC8032462.
   PubMed Web of Science ®Google Scholar